Bifogade filer
Kurs
+0,14%
Likviditet
25,9 MSEK
Kalender
| Est. tid* | ||
| 2026-06-05 | 08:20 | Bokslutskommuniké 2026 |
| 2026-03-06 | 08:20 | Kvartalsrapport 2026-Q3 |
| 2025-12-12 | 08:20 | Kvartalsrapport 2026-Q2 |
| 2025-09-10 | - | X-dag bonusutdelning SECT B 1 |
| 2025-09-10 | - | X-dag ordinarie utdelning SECT B 1.10 SEK |
| 2025-09-09 | - | Årsstämma |
| 2025-09-04 | - | Kvartalsrapport 2026-Q1 |
| 2025-06-05 | - | Bokslutskommuniké 2025 |
| 2025-03-14 | - | Kvartalsrapport 2025-Q3 |
| 2024-12-12 | - | Kvartalsrapport 2025-Q2 |
| 2024-10-07 | - | Inlösen SECT B 1.1 |
| 2024-09-11 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2024-09-10 | - | Årsstämma |
| 2024-09-06 | - | Kvartalsrapport 2025-Q1 |
| 2024-06-05 | - | Bokslutskommuniké 2024 |
| 2024-03-08 | - | Kvartalsrapport 2024-Q3 |
| 2023-12-15 | - | Kvartalsrapport 2024-Q2 |
| 2023-10-09 | - | Inlösen SECT B 1.1 |
| 2023-09-08 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2023-09-07 | - | Årsstämma |
| 2023-09-05 | - | Kvartalsrapport 2024-Q1 |
| 2023-06-02 | - | Bokslutskommuniké 2023 |
| 2023-03-10 | - | Kvartalsrapport 2023-Q3 |
| 2022-12-16 | - | Kvartalsrapport 2023-Q2 |
| 2022-10-10 | - | Inlösen SECT B 1 |
| 2022-09-09 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2022-09-08 | - | Årsstämma |
| 2022-09-02 | - | Kvartalsrapport 2023-Q1 |
| 2022-06-03 | - | Bokslutskommuniké 2022 |
| 2022-03-09 | - | Kvartalsrapport 2022-Q3 |
| 2021-12-10 | - | Kvartalsrapport 2022-Q2 |
| 2021-10-18 | - | Inlösen SECT B 0.9 |
| 2021-09-24 | - | Split SECT B 1:5 |
| 2021-09-15 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2021-09-14 | - | Årsstämma |
| 2021-09-03 | - | Kvartalsrapport 2022-Q1 |
| 2021-06-02 | - | Bokslutskommuniké 2021 |
| 2021-03-12 | - | Kvartalsrapport 2021-Q3 |
| 2020-11-27 | - | Kvartalsrapport 2021-Q2 |
| 2020-10-05 | - | Inlösen SECT B 4.5 |
| 2020-09-09 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2020-09-08 | - | Årsstämma |
| 2020-09-04 | - | Kvartalsrapport 2021-Q1 |
| 2020-06-03 | - | Bokslutskommuniké 2020 |
| 2020-03-04 | - | Kvartalsrapport 2020-Q3 |
| 2019-11-28 | - | Kvartalsrapport 2020-Q2 |
| 2019-10-02 | - | Inlösen SECT B 4.5 |
| 2019-09-06 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2019-09-05 | - | Årsstämma |
| 2019-09-03 | - | Kvartalsrapport 2020-Q1 |
| 2019-05-28 | - | Bokslutskommuniké 2019 |
| 2019-03-06 | - | Kvartalsrapport 2019-Q3 |
| 2018-12-07 | - | Kvartalsrapport 2019-Q2 |
| 2018-10-03 | - | Inlösen SECT B 4.5 |
| 2018-09-07 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2018-09-06 | - | Årsstämma |
| 2018-09-04 | - | Kvartalsrapport 2019-Q1 |
| 2018-05-29 | - | Bokslutskommuniké 2018 |
| 2018-03-12 | - | Kvartalsrapport 2018-Q3 |
| 2017-12-08 | - | Kvartalsrapport 2018-Q2 |
| 2017-10-02 | - | Inlösen SECT B 4.5 |
| 2017-09-14 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2017-09-13 | - | Årsstämma |
| 2017-09-12 | - | Kvartalsrapport 2018-Q1 |
| 2017-05-30 | - | Bokslutskommuniké 2017 |
| 2017-03-07 | - | Kvartalsrapport 2017-Q3 |
| 2016-12-07 | - | Kvartalsrapport 2017-Q2 |
| 2016-10-04 | - | Inlösen SECT B 4.5 |
| 2016-09-07 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2016-09-06 | - | Årsstämma |
| 2016-09-05 | - | Kvartalsrapport 2017-Q1 |
| 2016-05-31 | - | Bokslutskommuniké 2016 |
| 2016-03-08 | - | Kvartalsrapport 2016-Q3 |
| 2015-12-08 | - | Kvartalsrapport 2016-Q2 |
| 2015-09-28 | - | Inlösen SECT B 4.5 |
| 2015-09-15 | - | Kapitalmarknadsdag 2015 |
| 2015-09-08 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2015-09-07 | - | Årsstämma |
| 2015-09-07 | - | Kvartalsrapport 2016-Q1 |
| 2015-06-03 | - | Bokslutskommuniké 2015 |
| 2015-03-10 | - | Kvartalsrapport 2015-Q3 |
| 2014-12-09 | - | Kvartalsrapport 2015-Q2 |
| 2014-09-25 | - | Inlösen SECT B 4.5 |
| 2014-09-09 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2014-09-08 | - | Årsstämma |
| 2014-09-08 | - | Kvartalsrapport 2015-Q1 |
| 2014-05-27 | - | Bokslutskommuniké 2014 |
| 2014-03-04 | - | Kvartalsrapport 2014-Q3 |
| 2013-12-10 | - | Kvartalsrapport 2014-Q2 |
| 2013-09-10 | - | Kvartalsrapport 2014-Q1 |
| 2013-07-11 | - | Inlösen SECT B 4.5 |
| 2013-06-28 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2013-06-27 | - | Årsstämma |
| 2013-05-29 | - | Bokslutskommuniké 2013 |
| 2013-05-28 | - | Analytiker möte 2013 |
| 2013-05-28 | - | Bokslutskommuniké 2012 |
| 2013-03-06 | - | Kapitalmarknadsdag 2013 |
| 2013-03-05 | - | Kvartalsrapport 2012-Q3 |
| 2012-12-04 | - | Kvartalsrapport 2012-Q2 |
| 2012-09-04 | - | Kvartalsrapport 2012-Q1 |
| 2012-07-12 | - | Inlösen SECT B 5 |
| 2012-06-29 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2012-06-28 | - | Årsstämma |
| 2012-05-22 | - | Analytiker möte 2011 |
| 2012-05-21 | - | Bokslutskommuniké 2011 |
| 2012-03-05 | - | Kvartalsrapport 2011-Q3 |
| 2011-12-06 | - | 15-7 2011 |
| 2011-12-05 | - | Inlösen SECT B 5 |
| 2011-12-04 | - | Kvartalsrapport 2011-Q2 |
| 2011-11-23 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2011-11-22 | - | Extra Bolagsstämma 2011 |
| 2011-09-04 | - | Kvartalsrapport 2011-Q1 |
| 2011-05-24 | - | Bokslutskommuniké 2010 |
| 2011-03-08 | - | Kvartalsrapport 2010-Q3 |
| 2010-07-01 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2010-06-30 | - | Årsstämma |
| 2010-05-25 | - | Bokslutskommuniké 2009 |
| 2010-03-16 | - | Kvartalsrapport 2009-Q3 |
| 2009-12-08 | - | Kvartalsrapport 2009-Q2 |
| 2009-09-14 | - | Kvartalsrapport 2009-Q1 |
| 2009-06-29 | - | X-dag ordinarie utdelning SECT B 0.00 SEK |
| 2009-06-26 | - | Årsstämma |
| 2008-06-26 | - | X-dag ordinarie utdelning SECT B 0.50 SEK |
| 2007-06-29 | - | X-dag ordinarie utdelning SECT B 0.50 SEK |
| 2006-06-29 | - | X-dag ordinarie utdelning SECT B 0.50 SEK |
| 2000-08-11 | - | Split SECT B 1:3 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Linköping, Sweden - October 16, 2025 - International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has expanded its pre-operative planning solution for orthopaedic trauma cases with 3D templates from one of the world's leading medical equipment companies, Smith+Nephew. Extending the range of templates in Sectra's solution supports a broader adoption of digital pre-operative planning, a key enabler of patient-specific treatments, which improves operational efficiency and patient outcomes.
Paul Tornetta III, MD, Director of orthopaedic trauma at Boston Medical Center, and Professor and Chair of the Department of Orthopaedic Surgery at the Chobanian & Avedisian School of Medicine of Boston University, emphasizes the broad impact of Sectra's orthopaedic offering-implemented at his institution in 2023-on both clinical care and training:
"3D planning in orthopaedics is rapidly advancing and promises to play an important role in improving the efficiency and outcomes of trauma care. Sectra's integrated planning tools incorporating implant templates from leading brands like Smith+Nephew enhance our ability to prepare for complex procedures with precision and confidence."
He continues:
"Beyond surgical precision, this platform is also a powerful educational tool. It allows us to train residents more effectively; walking through real cases, demonstrating best practices, and helping them build a strong foundation in orthopaedic trauma decision-making. This dual impact, on patient care and surgical education, makes it a transformative addition to our practice."
Sectra's 3D pre-operative planning solution for trauma enables surgeons to visualize fractures in an interactive 3D environment. With tools such as advanced bone segmentation, the surgeon can study and understand the fracture and determine the most suitable approach and implant choice prior to surgery. Digital preparation minimizes the risk of surprises and stress during surgery and consequently can shorten the time spent in the operating room. Additionally, it reduces the number of prostheses that need to be prepared ahead of surgery, which lowers overhead costs. For patients, shorter operations mean less risk of infections and complications.
"By incorporating a broad range of implants, we can greatly enhance the planning process for a large portion of our product's users. With this expansion, our 3D template library now covers nearly 80% of the orthopaedic trauma market. I'm proud to offer a solution that supports and advances pre-operative planning for surgeons, ultimately improving the overall patient experience," says Gustaf Schwang, President of Sectra Orthopaedics AB.
Sectra's 3D pre-operative planning solution is part of Sectra's enterprise imaging solution which provides a unified strategy for all imaging needs in one single system thus both improving outcomes as well as lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise without acquiring a new back end. Visit Sectra's website to read more about Sectra and why it's top-ranked in "Best in KLAS".
Disclaimer and Disclosures
Smith+Nephew's products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets.
Dr. Paul Tornetta III serves as a consultant and designer to Smith+Nephew and receives royalty payments under license agreements.
About Sectra
Sectra contributes to a healthier and safer society by assisting health systems throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. The company, founded in 1978, is headquartered in Linköping, Sweden, with direct sales in 19 countries, and distribution partners worldwide. Sales in the 2024/2025 fiscal year totaled SEK 3,240 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit Sectra's website. For more information, visit Sectra's website.
For further information, please contact:
Dr. Torbjörn Kronander, CEO and President Sectra AB, +46 (0) 705 23 52 27
Gustaf Schwang, President, Sectra Orthopaedics AB, +46 (0) 734 16 08 10